Live feed07:26:23·772dNEWSReleasevia Quantisnow+2AstraZeneca's $2.4B Fusion Pharmaceuticals' Acquisition Signals Shift In Efforts From Traditional Regimens For More Targeted Cancer TreatmentsByQuantisnow·Wall Street's wire, on your screen.AZN· AstraZeneca PLCBMY· Bristol-Myers Squibb CompanyFUSN· Fusion Pharmaceuticals Inc.LLY· Eli Lilly and CompanyRYZB· RayzeBio Inc.Health Care
